IDEAYA Biosciences, Inc.
IDYA
$40.17
$0.220.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 828.96M | 671.20M | 639.39M | 786.89M | 669.74M |
| Total Receivables | 15.42M | 6.56M | 5.97M | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 19.65M | 18.35M | 21.37M | 15.76M | 15.86M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 864.03M | 696.11M | 666.73M | 802.66M | 685.60M |
|
|
|||||
| Total Current Assets | 864.03M | 696.11M | 666.73M | 802.66M | 685.60M |
| Net Property, Plant & Equipment | 30.46M | 31.25M | 31.29M | 31.72M | 32.73M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.28M | 1.28M | 1.02M | 805.00K | 805.00K |
| Total Assets | 1.31B | 1.03B | 1.11B | 1.19B | 1.04B |
|
|
|||||
| Total Accounts Payable | 30.51M | 20.74M | 17.58M | 18.43M | 17.27M |
| Total Accrued Expenses | 50.98M | 43.75M | 40.89M | 45.26M | 37.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.19M | 350.00K | 339.00K | 328.00K | 318.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 490.00K | -- |
| Total Other Current Liabilities | -- | -- | -- | 490.00K | -- |
| Total Current Liabilities | 82.68M | 64.83M | 58.82M | 64.51M | 55.34M |
|
|
|||||
| Total Current Liabilities | 82.68M | 64.83M | 58.82M | 64.51M | 55.34M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 28.12M | 28.25M | 27.58M | 26.92M | 26.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 1.68M | -- |
| Total Liabilities | 110.79M | 93.08M | 86.39M | 93.10M | 81.62M |
|
|
|||||
| Common Stock & APIC | 2.15B | 1.77B | 1.76B | 1.74B | 1.73B |
| Retained Earnings | -947.53M | -835.08M | -736.54M | -653.27M | -772.51M |
| Treasury Stock & Other | -1.67M | -494.00K | 2.27M | 2.05M | 1.52M |
| Total Common Equity | 1.20B | 937.27M | 1.02B | 1.09B | 959.65M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.20B | 937.27M | 1.02B | 1.09B | 959.65M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.20B | 937.27M | 1.02B | 1.09B | 959.65M |
|
|
|||||